FDA Reviewers Flag Cancer Risk in Diabetes Drug - MedPage Today

[INCIID News Feed]

ThirdAge
<img alt="" height="1" width="1" />
FDA Reviewers Flag Cancer Risk in Diabetes Drug
MedPage Today
WASHINGTON -- FDA reviewers said the novel diabetes drug dapagliflozin appears effective at treating diabetes, but may pose breast and bladder cancer risks as well as liver toxicity. ...
FDA questions safety of experimental diabetes drugBusinessWeek
Diabetes Mellitus Drug Dapagliflozin Raises Serious Liver and Cancer RisksThirdAge
AstraZeneca, Bristol diabetes pill has risks - FDAReuters
Bloomberg -CalorieLab Calorie Counter News -FierceBiotech
all 142 news articles &raquo;


More...